
Economic evaluations of adjuvant trastuzumab were reviewed. Three primary shortcomings were identified including incorporation of local data and estimation and representation (visual) of decision uncertainty.

Economic evaluations of adjuvant trastuzumab were reviewed. Three primary shortcomings were identified including incorporation of local data and estimation and representation (visual) of decision uncertainty.

India's emerging health insurance sector faces significant operational challenges that managed care models can help to address.

There is a critical need for comparative information about plan resource use to support value-based purchasing efforts.